Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine insulin for perioperative hyperglycemic control in type 2 diabetic patients undergoing off-pump CABG
IRCT20130428013159N11Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Perioperative blood glucose. Started Apr 2020; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20130428013159N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130428013159N11.